Clinical & Economic Evidence: A Bridge to Value
- Pharmacists are increasingly vital in health economics and outcomes research (HEOR), a field that bridges clinical practice and economic realities.
- HEOR uses cost-effectiveness analysis, including quality-adjusted life years (QALYs), to compare treatments.
- Pharmacists interpret clinical trial data and blend it with real-world outcomes to assess a therapy’s value.
Pharmacists play a crucial role in bridging clinical practice with economic realities, driving value in healthcare through health economics and outcomes research (HEOR). This article reveals how pharmacists are essential in evaluating therapies, ensuring their cost is justified by their benefits. Discover how HEOR uses cost-effectiveness analysis and budget impact models, providing real-world evidence to improve patient outcomes. Pharmacists interpret complex clinical trial data and translate it into actionable benefits, impacting treatment effectiveness and cost-effectiveness. This vital work builds trust and supports evidence-based decisions. Learn about an example project where a new biologic therapy’s value was assessed using real-world adherence data, decreasing hospitalizations, and improving life quality. News Directory 3 highlights teh impact of this critical intersection. Understand how pharmacists can lead the shift towards value-based care. Discover what’s next in this evolving field.
Pharmacists’ Crucial Role in Health Economics and Outcomes Research
Updated June 15, 2025
Pharmacists are increasingly vital in health economics and outcomes research (HEOR), a field that bridges clinical practice and economic realities. As treatments become more complex and healthcare budgets tighten, HEOR helps determine if a therapy’s cost is justified by its benefits.
HEOR uses cost-effectiveness analysis, including quality-adjusted life years (QALYs), to compare treatments. Budget impact models forecast how new treatments affect overall spending, informing formulary decisions. Real-world evidence captures treatment performance outside clinical trials, revealing adherence challenges and other practical issues.
Pharmacists interpret clinical trial data and blend it with real-world outcomes to assess a therapy’s value. They educate patients, manage adverse effects, and improve adherence, all of which impact a treatment’s real-world effectiveness and cost-effectiveness.
One project at a large health system evaluated a new biologic therapy for psoriasis.The team, including health economists, developed a budget impact model using real-world adherence data. Despite a high upfront cost, the therapy substantially reduced hospitalizations and improved life quality, resulting in a favorable cost-effectiveness ratio.
Pharmacists communicate HEOR findings to physicians, payers, and patients, translating complex data into meaningful details. This builds trust and ensures evidence-based decisions.
What’s next
Pharmacists are positioned to lead the shift toward value-based care, ensuring therapies are both effective and economically sustainable. Investing in HEOR training and collaboration will further enhance their impact on patient care and the healthcare system.